US Patent 7915042 Keratinocytes expressing exogenous angiogenic growth factors

Patent 7915042 was granted and assigned to Stratatech Corporation on March, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Stratatech Corporation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7915042

Date of Patent

March 29, 2011

Patent Application Number

12392221

Date Filed

February 25, 2009

Patent Citations Received

‌

US Patent 11911444 Use of human skin substitutes expressing exogenous IL-12 to treat a wound bed

Patent Primary Examiner

‌

Jane Zara

Patent abstract

The present invention relates to in vitro cultured skin tissue, and in particular to cultured skin tissue comprising exogenous genes encoding angiogenic growth factors. In some embodiments, the keratinocytes express exogenous angiopoietin-1 or a member of the VEGF family, preferably VEGF-A. In particularly preferred embodiments, the keratinocytes are incorporated into cultured skin tissue.